Skip to main content
R

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,677 across all filing types
Latest filing 2026-04-24 Remuneration Information
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
瑞康医药集团股份有限公司董事、高级管理人员薪酬管理制度（1）
Remuneration Information Classification · 1% confidence The document is a formal corporate policy titled “董事、高级管理人员薪酬管理制度,” detailing the structure, principles, committees, and rules for directors’ and senior management’s compensation. It specifies remuneration components, performance linkage, adjustment, deferral, and recovery mechanisms. This aligns precisely with a Remuneration Information report, which details executive and director compensation arrangements. Therefore, it should be classified under Remuneration Information (Code: DEF 14A).
2026-04-24 Chinese
2025年内部控制自我评价报告
Audit Report / Information Classification · 1% confidence The document is a full-length, standalone internal control self-evaluation report (“内部控制自我评价报告”) detailing the company’s internal control framework, evaluation conclusions, defect definitions, and remediation status. It is not an announcement of a report nor part of a broader Annual Report; rather, it is a specific audit-related disclosure on internal controls, fitting the definition of a standalone audit report or audit information. Therefore, it aligns with the “Audit Report / Information (AR)” category.
2026-04-22 Chinese
第五届董事会第二十一次会议决议的公告
Report Publication Announcement Classification · 1% confidence The document is an announcement of the board of directors’ resolutions, primarily approving and authorizing the company’s 2025 Annual Report, its summary, related work reports, and a profit distribution plan, and noting that the full annual report is published on the CNINFO website. The text is short (<5,000 characters) and serves to notify stakeholders of the report’s approval and publication rather than presenting the full report itself. Under the “menu vs meal” rule, this fits the description of a Report Publication Announcement (RPA).
2026-04-22 Chinese
公司对2025年度会计师事务所履职情况的评估报告
Governance Information Classification · 1% confidence The document is a Board report evaluating the performance and independence of the 2025 annual audit firm (深圳久安会计师事务所) under corporate governance and regulatory requirements. It is not the annual report itself, nor is it an audit opinion report; instead, it reflects the Board/Audit Committee’s governance oversight of the external auditor. This aligns with Governance Information (CGR).
2026-04-22 Chinese
2025年年度审计报告
Audit Report / Information Classification · 1% confidence The document is a standalone audit report issued by Shenzhen Jiuan CPAs, containing audit opinions, basis of opinion, key audit matters, auditor responsibilities, and the full audited financial statements for the fiscal year ended December 31, 2025. It does not constitute a full annual report or regulatory notice but is clearly an Audit Report. Therefore, the appropriate classification is AR (Audit Report / Information).
2026-04-22 Chinese
关于举办2025年度网上业绩说明会的公告
Investor Presentation Classification · 1% confidence The document is an announcement by the company’s board about hosting its 2025 online performance briefing (业绩说明会) for investors. It is not the annual report itself, nor a regulatory filing or earnings release, but rather a notice of an investor presentation/webcast event. Therefore, the best fit is Investor Presentation (IP).
2026-04-22 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.